| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal expression of TFIIIB subunits and RNA Pol III genes is associated with hepatocellular carcinoma
|
Lei, Junxia
|
|
2017
|
|
2 |
p. 112-120
9 p.
|
artikel
|
| 2 |
Activating transcription factor 3 in immune response and metabolic regulation
|
Jadhav, Kavita
|
|
2017
|
|
2 |
p. 96-102
7 p.
|
artikel
|
| 3 |
Advances in the role of follicular T helper cells in graft versus host diseases
|
Chen, Maogen
|
|
2017
|
|
2 |
p. 131-134
4 p.
|
artikel
|
| 4 |
Biliary endoscopy in the management of primary sclerosing cholangitis and its complications
|
Fung, Brian M.
|
|
2019
|
|
2 |
p. 106-117
|
artikel
|
| 5 |
Camrelizumab (SHR-1210) treatment for recurrent hepatocellular carcinoma after liver transplant: A report of two cases
|
Dai, Tianxing
|
|
|
|
2 |
p. 111-115
|
artikel
|
| 6 |
Chinese expert consensus on evaluation of donor and donor liver for split liver transplantation
|
|
|
|
|
2 |
p. 59-65
|
artikel
|
| 7 |
Clinical perspectives of isoniazid-induced liver injury
|
Lei, Saifei
|
|
|
|
2 |
p. 45-52
|
artikel
|
| 8 |
Corrigendum to “Deficiency of pyruvate dehydrogenase kinase 4 sensitizes mouse liver to diethylnitrosamine and arsenic toxicity through inducing apoptosis” [Liver Res. 2 (2018) 100–107]
|
Choiniere, Jonathan
|
|
|
|
2 |
p. 164
|
artikel
|
| 9 |
Deficiency of pyruvate dehydrogenase kinase 4 sensitizes mouse liver to diethylnitrosamine and arsenic toxicity through inducing apoptosis
|
Choiniere, Jonathan
|
|
2018
|
|
2 |
p. 100-107
|
artikel
|
| 10 |
Diagnosis and treatment of icteric hepatitis caused by erythropoietic protoporphyria: A case report
|
Huang, Hanqing
|
|
|
|
2 |
p. 116-120
|
artikel
|
| 11 |
Dysregulation of glutathione synthesis in liver disease
|
Lu, Shelly C.
|
|
|
|
2 |
p. 64-73
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
|
2 |
p. ii
|
artikel
|
| 13 |
Editorial Board
|
|
|
2018
|
|
2 |
p. ii
|
artikel
|
| 14 |
Editorial Board
|
|
|
2019
|
|
2 |
p. ii
|
artikel
|
| 15 |
Editorial Board
|
|
|
|
|
2 |
p. ii
|
artikel
|
| 16 |
Editorial Board
|
|
|
|
|
2 |
p. ii
|
artikel
|
| 17 |
Editorial Board
|
|
|
|
|
2 |
p. ii
|
artikel
|
| 18 |
Effects of Bacillus Calmette-Guérin on immunometabolism, microbiome and liver diseases
|
Ijaz, Muhammad Umair
|
|
|
|
2 |
p. 116-123
|
artikel
|
| 19 |
Effects of intestine-specific deletion of fibroblast growth factor 15 on alcoholic liver disease development in mice
|
Kong, Bo
|
|
|
|
2 |
p. 84-92
|
artikel
|
| 20 |
Efficacy and safety of direct-acting antiviral agent regimens in a real-world cohort of adult Chinese patients with chronic hepatitis C virus infection
|
Wei, Jinyuan
|
|
|
|
2 |
p. 101-107
|
artikel
|
| 21 |
Emerging role of the orphan nuclear receptor estrogen-related receptor gamma in liver metabolic diseases
|
Kim, Don-Kyu
|
|
2019
|
|
2 |
p. 99-105
|
artikel
|
| 22 |
Emerging roles of DJ-1 in liver diseases through regulation of oxidative stress and immune response
|
Xu, Min
|
|
2018
|
|
2 |
p. 87-91
|
artikel
|
| 23 |
Emerging signals regulating liver tumor initiating cells
|
Chen, Jingyu
|
|
2018
|
|
2 |
p. 73-80
|
artikel
|
| 24 |
Expert consensus on perioperative management of liver transplantation in adults with acute-on-chronic liver failure
|
|
|
|
|
2 |
p. 37-44
|
artikel
|
| 25 |
Expert consensus on the role of hematological markers in the early clinical screening of hepatocellular carcinoma
|
|
|
|
|
2 |
p. 66-71
|
artikel
|
| 26 |
Functions of hepatic non-parenchymal cells in alcoholic liver disease
|
Choi, Won-Mook
|
|
2019
|
|
2 |
p. 80-87
|
artikel
|
| 27 |
Glucokinase activator improves glucose tolerance and induces hepatic lipid accumulation in mice with diet-induced obesity
|
Cai, Nan
|
|
|
|
2 |
p. 124-135
|
artikel
|
| 28 |
Hepatic progenitor cell activation in liver repair
|
Bria, Adam
|
|
2017
|
|
2 |
p. 81-87
7 p.
|
artikel
|
| 29 |
Hsa-miR-637 inhibits human hepatocyte proliferation by targeting Med1-interacting proteins
|
Liu, Jing
|
|
|
|
2 |
p. 88-96
|
artikel
|
| 30 |
Human embryoid bodies to hepatocyte-like clusters: Preparing for translation
|
Pettinato, Giuseppe
|
|
2017
|
|
2 |
p. 88-95
8 p.
|
artikel
|
| 31 |
Immunotherapy as adjuvant therapy for a patient with adenosquamous carcinoma of the intrahepatic bile duct: A case report and literature review
|
Feng, Jun
|
|
|
|
2 |
p. 156-160
|
artikel
|
| 32 |
Integrative analysis of bulk and single-cell RNA sequencing data reveals distinct subtypes of MAFLD based on N1-methyladenosine regulator expression
|
He, Jinyong
|
|
|
|
2 |
p. 145-155
|
artikel
|
| 33 |
Intestinal barrier function and metabolic/liver diseases
|
Ghosh, Siddhartha S.
|
|
|
|
2 |
p. 81-87
|
artikel
|
| 34 |
Liver-specific deletion of mechanistic target of rapamycin does not protect against acetaminophen-induced liver injury in mice
|
Sun, Hua
|
|
|
|
2 |
p. 79-87
|
artikel
|
| 35 |
Loss of hepatic VMP1 trapped VLDL in the bilayer of endoplasmic reticulum membrane
|
Ni, Hong-Min
|
|
|
|
2 |
p. 161-163
|
artikel
|
| 36 |
Mesenchymal stem cells for treatment of steroid-resistant acute rejection after liver transplantation
|
Zhang, Yingcai
|
|
2017
|
|
2 |
p. 140-145
6 p.
|
artikel
|
| 37 |
Mesenchymal stem cells therapy for acute liver failure: Recent advances and future perspectives
|
Luan, Yuling
|
|
|
|
2 |
p. 53-61
|
artikel
|
| 38 |
Methionine adenosyltransferases in liver health and diseases
|
Ramani, Komal
|
|
2017
|
|
2 |
p. 103-111
9 p.
|
artikel
|
| 39 |
MiR-22 as a metabolic silencer and liver tumor suppressor
|
Wang, Lijun
|
|
|
|
2 |
p. 74-80
|
artikel
|
| 40 |
Neuroendocrine tumors with hepatic metastases: A review of evolving treatment options
|
Colquhoun, Steven D.
|
|
2018
|
|
2 |
p. 92-99
|
artikel
|
| 41 |
Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
|
Bashir, Aamir
|
|
|
|
2 |
p. 72-83
|
artikel
|
| 42 |
Novel organoid model in drug screening: Past, present, and future
|
Nie, Xialin
|
|
|
|
2 |
p. 72-78
|
artikel
|
| 43 |
Nuclear receptors and non-alcoholic fatty liver disease: An update
|
Yang, Xiao
|
|
|
|
2 |
p. 88-93
|
artikel
|
| 44 |
Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogue
|
Wu, Li-Li
|
|
|
|
2 |
p. 136-144
|
artikel
|
| 45 |
Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist
|
Malik, Adnan
|
|
2019
|
|
2 |
p. 118-127
|
artikel
|
| 46 |
Primary biliary cholangitis: Diagnosis and treatment
|
Chew, Michael
|
|
2018
|
|
2 |
p. 81-86
|
artikel
|
| 47 |
Progress on clinical prognosis assessment in liver failure
|
Cai, Xianghao
|
|
|
|
2 |
p. 101-107
|
artikel
|
| 48 |
Protective effects of Longhu Rendan on chronic liver injury and fibrosis in mice
|
Yang, Guizhi
|
|
|
|
2 |
p. 93-102
|
artikel
|
| 49 |
Quantification of liver fat deposition in obese and diabetic patients: A pilot study on the correlation with myocardium and periapical fat content
|
Chen, Xi
|
|
|
|
2 |
p. 103-110
|
artikel
|
| 50 |
Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects
|
Wang, Hongye
|
|
|
|
2 |
p. 108-115
|
artikel
|
| 51 |
Risk assessment and management of hepatitis B reactivation from direct-acting antivirals for hepatitis C
|
Whitsett, Maureen
|
|
2019
|
|
2 |
p. 75-79
|
artikel
|
| 52 |
Roles of microRNA in liver cancer
|
Tao, Junyan
|
|
2018
|
|
2 |
p. 61-72
|
artikel
|
| 53 |
Stopping nucleos(t)ide analog treatment in chronic hepatitis B — Who and when?
|
Kho-Herman, Suzette Grace R.
|
|
2017
|
|
2 |
p. 135-139
5 p.
|
artikel
|
| 54 |
The acidic pathway of bile acid synthesis: Not just an alternative pathway
|
Pandak, William M.
|
|
2019
|
|
2 |
p. 88-98
|
artikel
|
| 55 |
The metabolite, alpha-ketoglutarate inhibits non-alcoholic fatty liver disease progression by targeting lipid metabolism
|
Nagaoka, Katsuya
|
|
|
|
2 |
p. 94-100
|
artikel
|
| 56 |
Ulcerative colitis triggered by pegylated interferon alpha-2b in a patient with chronic hepatitis B: A case report and literature review
|
Mo, Zhishuo
|
|
|
|
2 |
p. 97-101
|
artikel
|
| 57 |
Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis
|
Chiang, John Y.L.
|
|
|
|
2 |
p. 47-63
|
artikel
|
| 58 |
Vitamins and non-alcoholic fatty liver disease: A molecular insight
|
Raza, Sana
|
|
|
|
2 |
p. 62-71
|
artikel
|
| 59 |
Wilson disease: At the crossroads between genetics and epigenetics—A review of the evidence
|
Kieffer, Dorothy A.
|
|
2017
|
|
2 |
p. 121-130
10 p.
|
artikel
|
Tijdschrift beschrijving